A Harvard-led study found that Type 2 diabetes was associated with a higher risk for several types of cancer, with risk peaking less than a decade after diagnosis.
Research continues to show that more aggressive surgical treatment is not always better for some breast cancer patients, yet many physicians and patients continue to opt for the maximalist approach. Is change possible?
Boston Scientific is testing new, larger yttrium-90 TheraSphere beads for treatment of colorectal cancer patients with liver metastases (mCRC). The beads are already FDA-approved for selective internal radiation therapy for patients with unresectable...
Researchers claim immunotherapy may offer improved outcomes for patients experiencing HRP ovarian cancer.
Researchers at St. Jude Children’s Research Hospital found that adding a novel anti-disialoganglioside GD2 (anti-GD2) monoclonal antibody to the standard therapy for children newly diagnosed with high-risk neuroblastoma significantly enhanced response to treatment and improved survival. Their findings could be transformative if additional studies can produce similar results.
New data indicates patients report myocarditis at higher rates after the use of immune checkpoint inhibitors during cancer treatment.
New guidelines have lowered the recommended starting age for colorectal cancer screening. One expert says clinicians need to do more to increase screening access and compliance while ensuring no patient population is left behind.
A tailor-made oncology treatment, CAR T-cell therapy promises to transform cancer care. But can its potential overcome its problems?
Galleri, a test developed by California-based healthcare company Grail, can detect dozens of types of cancer — most of which currently lack a recommended screening test — with a single blood sample. What could that mean for the way clinicians screen for and treat cancer?
Just as in politics and the energy business, hacking hospital systems is on the rise — and it’s not just patient privacy that’s at risk. In April, a security breach of oncology and radiology system provider Elekta took the radiation systems of numerous...
- 1 of 11
- next ›